Children wearing spectacle lenses: mobility during everyday activities
Official title: Mobility Performance in Daily Activities Among Children Wearing Single Vision and Myopia Control Spectacle Lenses
Run by SightGlass Vision, Inc. · NCT07229352 · Data updated 2026-11-12
This test checks whether myopia-control spectacle lenses change how children aged 6–12 move and perform everyday mobility tasks compared with regular single-vision glasses.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 6 Years to 12 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | SightGlass Vision, Inc. Industry-sponsored |
| Locations | 1 site (Glendale, Arizona) |
| Status | Recruiting |
| Started | February 2, 2026 |
| Main results expected | December 31, 2027 |
| Study ends | July 1, 2028 |
| Registry record updated | November 5, 2026 |
| Trial ID | NCT07229352 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children aged 6–12 who can achieve 20/20 vision with correction, have no active ocular disease, have not recently used myopia-control treatments, and whose parent or guardian can provide informed consent and attend study visits.
✕Probably not a fit
Children outside the 6–12 age range, those who cannot achieve 20/20 vision with correction, have active ocular or excluded systemic disease, or are currently on myopia-control treatments are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Children aged 6 to 12 who meet vision and health criteria will be fitted with either standard single-vision spectacle lenses (control) or a novel myopia-control spectacle lens design (test) and will perform a series of everyday mobility tasks during in-person visits. The study compares mobility performance between the two lens types using structured tasks and observational measures to capture real-world functional effects. Participants must be able to achieve 20/20 with correction, have no active ocular disease, and have not been undergoing other myopia-control treatments. Visits are conducted at a single clinical site where trained staff record performance and adherence to lens wear instructions.
Why it matters
Potential benefit: If successful, the results could show that myopia-control spectacle lenses do not impair—and may be safely used without reducing—children's mobility in daily activities, supporting clinician and parent confidence in prescribing them.
How similar studies have gone: Previous trials of myopia-control lens designs have shown success in slowing refractive progression, but relatively few studies have specifically examined effects on children's mobility and everyday functional tasks, so this focus is partly novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: A participant is eligible for inclusion in the study if they meet the following criteria: * Are between the ages of 6 and 12 years of age (inclusive) at the time of informed consent/assent. * Can achieve a corrected visual acuity of 20/20 best-corrected (or equivalent logMAR). * Have undergone a self-reported oculo-visual examination within the past two years. * Have no active ocular disease. * Are willing and able to adhere to instructions, study procedures, and maintain the appointment schedule. * Have not previously worn or participated in myopia control contact lenses for more than one month and are not currently undergoing any form of myopia control treatment. * The subject's parent(s) or legal guardian(s) must read, understand, and sign the Statement of Informed Consent and receive a fully executed copy of the form. Exclusion Criteria: A participant will be excluded from the study if they meet any of the following conditions: * Have any systemic disease that affects ocular health. * Are currently using or have used, within the past 7 days, any systemic or topical medications that may impact ocular health. * Are currently using or have used any topical ophthalmic agents with anti-muscarinic properties within 7 days prior to enrollment or at any point during the study. This includes, but is not limited to, atropine, scopolamine, pirenzepine, tropicamide, cyclopentolate, and homatropine. * Have used any oral agents with anti-muscarinic properties for a chronic period (2 months or more) or short-term (within 7 days prior to enrollment). This includes, but is not limited to, gastrointestinal anti-spasmodic medications containing atropine, hyoscyamine, and dicyclomine. * Have known developmental delays. * Have participated in another clinical study in the last 7 days
Where it's running
-
Midwestern University Arizona College of Optometry
Glendale, Arizona, United States Recruiting
Study contacts
- Study coordinator: Jennifer Hill
- Email: jhill@sightglassvision.com
- Phone: 6783614877
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Where children look through their glasses
This trial tests how children ages 7–14 look through a new spectacle lens design to see which parts of the lens they use during different tasks.
-
Optimizing light exposure to prevent and control myopia in children
This study tests if changing classroom lighting to mimic sunlight or using a smartphone app to guide light exposure can help prevent and control myopia in primary school children.
-
Controlling myopia in young children with a new type of glasses
This study is testing a new type of glasses to see if they can help control the worsening of nearsightedness in children aged 6 to 8 years.
-
Using DIMS Glasses to See if Myopia Progression Slows in Kids
This observational study tests whether wearing DIMS glasses in children and teens with myopia can slow progression, considering factors like outdoor time and family history.
-
Continued use of DOT spectacle lenses for Chinese children
This will test whether DOT spectacle lenses slow myopia progression over 12 months in Chinese children who completed the earlier CATHAY study.
-
Evaluating a device for screening vision problems in young children
This study is testing a new device to see if it can effectively find vision problems in children aged 3 to 8, whether they wear glasses or not.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.